Physician profile
Robert C Garrett
NPI 1942726054
$4,086.60
in general payments reported to CMS, 2019-2025
9 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $65.43 · 2022: $3,791 · 2023: $15.71 · 2024: $113 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $229.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,180.36 | 2022 | |
| Cgg Medical INC | $571.89 | 2022 | |
| Axogen | $112.61 | 2024 | Axoguard Ha+ Nerve Protector, Axoguard Nerve Protector, Axoguard Nerve Cap |
| Ferring Pharmaceuticals INC. | $76.15 | 2021-2022 | |
| Bioventus LLC | $58.43 | 2025 | Exogen Ultrasound Bone Healing System, Xcell |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.44 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $22.08 | 2025 | |
| Avanos Medical | $20.93 | 2025 | On-Q Pump and Accessories |
| Kowa Pharmaceuticals America, INC. | $15.71 | 2023 | Livalo, Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Garrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.